SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000902664-19-004381
Filing Date
2019-11-18
Accepted
2019-11-18 21:56:28
Documents
1
Period of Report
2019-11-10

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 3277
  Complete submission text file 0000902664-19-004381.txt   5069
Mailing Address 1345 AVENUE OF THE AMERICAS 11TH FLOOR NEW YORK NY 10105
Business Address 1345 AVENUE OF THE AMERICAS 11TH FLOOR NEW YORK NY 10105 (347) 905 5663
Cellular Biomedicine Group, Inc. (Issuer) CIK: 0001378624 (see all company filings)

IRS No.: 861032927 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address ROOM 4503-5, 45/F, CHINA RESOURCES BLDG. 26 HARBOUR ROAD, WANCHAI HONG KONG F4 00000
Business Address ROOM 4503-5, 45/F, CHINA RESOURCES BLDG. 26 HARBOUR ROAD, WANCHAI HONG KONG F4 00000 852-2856-9300
Mission Right Ltd (Reporting) CIK: 0001612837 (see all company filings)

State of Incorp.: D8 | Fiscal Year End: 0331
Type: 3 | Act: 34 | File No.: 001-36498 | Film No.: 191228947